Company Number: 15055430

Analysis Date: 2025-07-20 15:58 UTC

1. Industry Classification
   TEBEV LIMITED operates under SIC code 47730, classified as "Dispensing chemist in specialised stores." This sector belongs to the wider retail pharmacy industry, characterized by the retail sale of medicinal drugs and related health products through specialized outlets. Key characteristics include regulatory compliance (e.g., with the General Pharmaceutical Council in the UK), reliance on both prescription and over-the-counter medication sales, and increasingly, diversification into health and wellness retail services. This sector typically features a mix of large national chains, regional players, and small independent chemists.

2. Relative Performance
   As a newly incorporated private limited company (incorporated August 2023), TEBEV LIMITED’s financial data for the year ending August 2024 shows very limited trading activity and scale. The balance sheet reveals net current liabilities of £1,159 and net liabilities overall, with minimal assets (£531 cash) and almost no share capital (£1). There are no reported revenues or turnover figures disclosed, suggesting either minimal or no commercial sales in its first year. In contrast, typical small-to-medium sized dispensing chemists in the UK sector report turnover ranging from hundreds of thousands to multiple millions of pounds annually, supported by significant stock holdings and receivables. TEBEV’s financial position is therefore below typical benchmarks for even micro or small pharmacy retailers, which usually maintain positive working capital and asset bases to manage inventory and regulatory compliance.

3. Sector Trends Impact
   The UK pharmacy retail sector is currently experiencing multiple dynamics:

• Increasing regulatory scrutiny and compliance costs related to dispensing and patient safety.
• Competitive pressure from large chain pharmacies and online medicine suppliers driving margin compression.
• Growing emphasis on complementary healthcare services (e.g., vaccination, health checks) as revenue diversification.
• Supply chain challenges and inflationary pressures impacting cost structures.
  For a startup like TEBEV LIMITED, these trends mean a high barrier to rapidly scaling operations and achieving profitability without significant initial investment in stock, premises, and qualified staff. The absence of turnover and negative net assets may reflect the early stage of market entry and investment phase, common for new entrants adapting to these sector conditions.

4. Competitive Positioning
   TEBEV LIMITED currently acts as a niche micro-enterprise within the dispensing chemist sector, likely targeting a local or specialty market given the limited scale and individual director ownership. Strengths include the director’s professional qualification as a pharmacist, which is crucial for regulatory compliance and client trust. However, weaknesses relative to typical competitors include:

• Minimal financial resources and negative net assets restricting operational flexibility.
• Lack of turnover or reported sales indicating initial market penetration challenges.
• Single employee structure limiting capacity for service diversification or high customer throughput.
• No disclosed stock or fixed assets, which are vital for inventory management in pharmacy retail.
  In comparison, established small to medium pharmacies maintain positive working capital, stock holdings, and multiple employees to support both retail and clinical service delivery. TEBEV’s current profile suggests it is in a pre-commercial or very early commercial phase, needing capital injection and operational development to compete effectively.